Table 1 Patients’ information used in current research in the GSE10186, TCGA and ICGC cohorts.
From: SAC3D1: a novel prognostic marker in hepatocellular carcinoma
GSE10186 (n = 80) | TCGA (n = 330) | ICGC (n = 237) | ||
|---|---|---|---|---|
Stage | I | — | 165 | — |
II | — | 80 | — | |
III | — | 82 | — | |
IV | — | 3 | — | |
Subgroups | Alcohol consumption | 47 | 103 | — |
Hepatitis B | 19 | 98 | — | |
Hepatitis C | 58 | 50 | — | |
